Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Share-based Compensation (2023 - 2025)

Fractyl Health (GUTS) has disclosed Share-based Compensation for 3 consecutive years, with $1.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Share-based Compensation fell 35.0% year-over-year to $1.6 million, compared with a TTM value of $7.7 million through Sep 2025, down 39.64%, and an annual FY2024 reading of $14.4 million, up 235.8% over the prior year.
  • Share-based Compensation was $1.6 million for Q3 2025 at Fractyl Health, down from $1.8 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $5.2 million in Q1 2024 and bottomed at $857000.0 in Q1 2023.
  • Average Share-based Compensation over 3 years is $2.1 million, with a median of $1.6 million recorded in 2025.
  • The sharpest move saw Share-based Compensation soared 508.75% in 2024, then plummeted 73.05% in 2025.
  • Year by year, Share-based Compensation stood at $1.3 million in 2023, then soared by 127.19% to $2.9 million in 2024, then tumbled by 43.5% to $1.6 million in 2025.
  • Business Quant data shows Share-based Compensation for GUTS at $1.6 million in Q3 2025, $1.8 million in Q2 2025, and $1.4 million in Q1 2025.